Lanzamiento Enero 2027

Ensayo controlado aleatorizado2024Financiado por la industriaVínculos de autores con la industriaAcceso abierto

Financiado en parte por Givaudan, Givaudan (France), Givaudan France Naturals

Wild Blueberry Extract Intervention in Healthy Older Adults: A Multi-Study, Randomised, Controlled Investigation of Acute Cognitive and Cardiovascular Effects

Cheng N, Barfoot KL, Le Cozannet R, Fança-Berthon P, Lamport DJ, Williams CM

Nutrients · 13 citas

Etiquetas de revisión

Vínculos de autores con la industriaFinanciado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
No se indica

Quién lo pagó

Financiación
Financiado por la industria
Empresa
Givaudan
Universidad u hospital
University of Reading
Empresa
Givaudan (France)
Empresa
Givaudan France Naturals
Autores
Al menos un autor declara un vínculo económico con la industria

Según 4 financiadores declarados y la declaración de financiación del texto completo.

Publicación

Publicado
2024-04-16 · Nutrients · vol. 16 · número 8 · pág. 1180
Editorial
Multidisciplinary Digital Publishing Institute
Citado
21 citas · más que el 94% de estudios similares · 3.6× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
59 trabajos
Acceso
Acceso abierto (revista) · CC-BY
Áreas de investigación
Phytochemicals and Antioxidant Activities · Dementia and Cognitive Impairment Research · Medicinal Plants and Neuroprotection
Palabras clave
anthocyanins, berries, cognitive decline, executive function, episodic memory, older adults, cardiovascular effects, blood pressure, heart rate, dose-response relationship, acute supplementation, healthy aging, attention, sleepiness, appetite, appetite regulation, appetite suppression
MeSH
humans, fruit, anthocyanins, plant extracts, cross-over studies, double-blind method, cognition, blood pressure, heart rate, postprandial period, dietary supplements, aged, female, male, executive function, memory, episodic, blueberry plants

6 autores

  • Nancy Cheng🇬🇧University of Reading
  • Katie L. Barfoot🇬🇧University of Reading
  • Romain Le Cozannet🇫🇷Givaudan (France)
  • Pascale Fança‐Berthon🇫🇷Givaudan (France)
  • Daniel Joseph Lamport🇬🇧University of Reading
  • Claire Michelle Williams🇬🇧 · autor de correspondenciaUniversity of Reading

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Circadian and homeostatic declines in cognitive performance are observed during the day, most commonly at 14:00. Additionally, postprandial reductions in cognitive ability have been widely demonstrated 1 h after lunch consumption, affecting domains of executive functioning (EF), episodic memory (EM), and attention. Existing evidence shows that anthocyanin-rich foods such as berries may improve or attenuate the decline in EF and EM in ageing adults. Further research is required to assess whether extracts such as wild blueberry extract (WBE) may be beneficial for cognitive function across an acute timeframe, including known periods of reduced functioning.

Objectives

(1) Study 1: ROAB: To investigate the efficacy of WBE in maintaining EF and EM throughout the day alongside measures of cardiovascular outcomes in healthy older adults. A range of WBE doses were utilised to identify the optimal dose at which cognitive and cardiovascular effects occur. (2) Study 2: BEAT: To replicate alleviation of cognitive decline during a predicted post-lunch dip whilst also improving cardiovascular outcomes following acute WBE 222 mg supplementation.

Methods

Both studies employed a randomised, double-blind, cross-over, placebo-controlled design to explore the effects of WBE intervention versus placebo on several outcomes, including EM, EF, blood pressure, and heart rate in a healthy older adult population (aged 68-75). In ROAB, 28 participants received a single dose of WBE 111 mg, 222 mg, 444 mg, or 888 mg or placebo over a 5-week period, each separated by a 1-week washout. Outcomes were measured at 0 h, 2 h, 4 h, and 6 h post intervention, with intervention occurring immediately after baseline (0 h). In BEAT, 45 participants received WBE 222 mg and placebo (1-week washout). Outcomes were measured at 0 h and 6 h (14:00) when a post-lunch dip was anticipated. This was further enhanced by consumption of lunch 1 h prior to cognitive testing. The WBE 222 mg intervention aligned with known peaks in plasma blueberry polyphenol metabolites at 2 h post dosing, which would coincide with a predicted drop in post-lunch performance.

Results

ROAB: A significant dip in executive function was apparent at the 4 h timepoint for placebo only, indicating attenuation for WBE doses. Strikingly, WBE 222 mg produced acute reductions in both systolic and diastolic blood pressure compared with placebo. BEAT: EF reaction time was found to be significantly faster for WBE 222 compared to placebo at the predicted post-lunch dip (14:00), with no other notable benefits on a range of cognitive and cardiovascular outcomes.

Conclusion

These two studies indicate that WBE may have cardiovascular benefits and attenuate the natural cognitive decline observed over the course of the day, particularly when a decline is associated with a circadian rhythm-driven postprandial dip. However, it is important to acknowledge that effects were subtle, and benefits were only observed on a small number of outcomes. Further research is required to explore the utility of WBE in populations already experiencing mild cognitive impairments.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.